The OEL (Occupational Exposure Limit) is an indicator that is used to prevent risks to the health of workers when handling chemical or dangerous substances. It is defined as the concentration in the air of a substance to which it is believed that workers could be repeatedly exposed throughout their working lives without suffering adverse […]
Read MoreDuring the month of June, Albian Group participates in the virtual event Achema Pulse, focused on new solutions in the chemical, biotechnology, pharmaceutical and food industry. The live event takes place on June 15 and 16, but its networking platform will be active throughout the month, through which we invite any participant or potential client […]
Read MoreAt Albian Group we celebrate a new achievement as we have been awarded of our first project in Saudi Arabia. The hard work of our team pays off and little by little we are present in more countries with our bespoke solutions for each client. We precisely want to convey our gratitude to this new […]
Read MoreYesterday, the Westin Hotel in Madrid hosted the 21st Century National Technology Awards ceremony. In this fourth edition, Ingeclima received the award in the Biotechnology category, which was collected by the CEO of Albian Group, Benigno Ferro. These awards recognize the work of all those companies that are responsible for great technological innovations and that […]
Read MoreAt Albian Group we are firmly committed to the UN Sustainable Development Goals, among which there is the goal of fighting climate change and working for the life of ecosystems. In line with this objective, our mission is to promote a responsible culture with the environment and take care of the environment, and that is […]
Read MoreAt Albian Group we are committed to the Sustainable Development Goals of the United Nations 2030 Agenda. In order to achieve the established goals, all agents of society must contribute, and as a company we are highly committed to this project. The policies dedicated to combating climate change are solidly internalized in the companies of […]
Read MoreAlbian Group has recently achieved a new milestone in its trajectory as we have been entrusted our first project in China. Step by step, and thanks to the efforts of the entire team, Albian Group is present in more and more countries. We would like to express our gratitude to our new client in China […]
Read MoreAdvances in clinical pharmacology and cancer research are fueling the rise of high potency active pharmaceutical ingredients (HPAPIs). A significant proportion of new drugs contain HPAPIs, which is leading to a spectacular increase in demand. Manufacturing HPAPIs is a complex process involving clean room processing operations with containment equipment and facilities. These processes are carried […]
Read MoreScientific research, the increasing countries that have legalized cannabis and the diffusion of information, have favored the medicinal use of cannabis. Although there are not many yet, there are several drugs derived from the cannabis plant and more and more pharmaceutical companies are aiming to produce drugs with this component, very useful in the treatment […]
Read MoreIn current medicine, one of the trends that is gaining more and more prominence is the use of genes, cells and tissues as a new therapeutic resource. This is known as advanced therapies: very innovative drugs that are based on gene, cell or tissue therapy to prevent or treat certain diseases. These advanced therapies are […]
Read More